BOOK
Emerging Respiratory Infections in the 21st Century, An Issue of Infectious Disease Clinics - E-Book
Alimuddin Zumla | Wing-Wai Yew | David S.C. Hui
(2010)
Additional Information
Book Details
Abstract
Respiratory infections are among the most common causes of morbidity and mortality worldwide. These infections present a special challenge to physicians for several reasons, including of the recent disasters caused by severe acute respiratory syndrome (SARS) and bird and swine influenza, the increase in viral and bacterial resistance to currently available anti-microbial drugs, the increased frequency of new viral lung infections in clinical practice, and the worldwide emergence of deadly drug-resistant forms of TB. For these reasons, it is important for infectious disease specialists to have an overview of emerging respiratory infections.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Contributors | iii | ||
| Contents | vii | ||
| Preface | xiii | ||
| Erratum | xvii | ||
| Chapter 1. Emerging Bacterial, Fungal, and Viral Respiratory Infections in Transplantation | 541 | ||
| EMERGING BACTERIAL RESPIRATORY INFECTIONS IN TRANSPLANTATION | 542 | ||
| EMERGING FUNGAL RESPIRATORY INFECTIONS IN TRANSPLANTATION | 544 | ||
| EMERGING VIRAL RESPIRATORY INFECTIONS IN TRANSPLANTATION | 547 | ||
| SUMMARY | 549 | ||
| REFERENCES | 549 | ||
| Chapter 2. Common and Emerging Fungal Pulmonary Infections | 557 | ||
| ENDEMIC MYCOSES | 558 | ||
| EMERGING PULMONARY MOLD INFECTIONS | 568 | ||
| EMERGING PULMONARY YEAST INFECTION: CRYPTOCOCCUS GATTII | 570 | ||
| SUMMARY | 572 | ||
| REFERENCES | 572 | ||
| Chapter 3. Emerging and Established Parasitic Lung Infestations | 579 | ||
| PROTOZOAL PARASITES | 579 | ||
| HELMINTHIC PARASITES | 584 | ||
| SUMMARY | 595 | ||
| REFERENCES | 596 | ||
| Chapter 4. Emerging, Novel, and Known Influenza Virus Infections in Humans | 603 | ||
| INFLUENZA VIRUSES | 603 | ||
| INFLUENZA PANDEMICS | 605 | ||
| CLINICAL FEATURES, DIAGNOSIS, AND MANAGEMENT OF INFLUENZA | 607 | ||
| PUBLIC HEALTH ISSUES: PREVENTION AND CONTROL | 612 | ||
| SUMMARY | 614 | ||
| REFERENCES | 614 | ||
| Chapter 5. Severe Acute Respiratory Syndrome and Coronavirus | 619 | ||
| THE VIRUS AND ITS ORIGIN | 619 | ||
| EPIDEMIOLOGY | 620 | ||
| CLINICAL FEATURES | 621 | ||
| LABORATORY FEATURES | 623 | ||
| RADIOLOGICAL FEATURES | 623 | ||
| PATHOGENESIS | 623 | ||
| IMMUNOBIOLOGY | 625 | ||
| TREATMENT | 625 | ||
| OUTCOMES | 628 | ||
| VACCINE DEVELOPMENT | 629 | ||
| SUMMARY | 630 | ||
| REFERENCES | 630 | ||
| Chapter 6. Respiratory Infections Due to Drug-Resistant Bacteria | 639 | ||
| CAP | 640 | ||
| HAP | 643 | ||
| REFERENCES | 647 | ||
| Chapter 7. Occupation-Related Respiratory Infections Revisited | 655 | ||
| RISK AND RISK FACTORS FOR TB INFECTION AND DISEASE | 656 | ||
| INTERVENTIONS TO PREVENT NOSOCOMIAL TB TRANSMISSION | 658 | ||
| SARS | 664 | ||
| INFLUENZA | 669 | ||
| SUMMARY | 670 | ||
| REFERENCES | 671 | ||
| Chapter 8. Pulmonary Infectious Complications of Tumor Necrosis Factor Blockade | 681 | ||
| TNF ANTAGONISTS | 681 | ||
| GRANULOMATOUS INFECTIONS | 682 | ||
| VIRAL INFECTIONS | 683 | ||
| STRUCTURE–FUNCTION RELATIONSHIP | 684 | ||
| LTBI DIAGNOSIS AND TREATMENT | 684 | ||
| MANAGEMENT OF INCIDENT TB CASES | 685 | ||
| REFERENCES | 687 | ||
| Chapter 9. The Convergence of the Global Smoking, COPD, Tuberculosis, HIV, and Respiratory Infection Epidemics | 693 | ||
| METHODOLOGY AND SEARCH STRATEGY | 694 | ||
| SMOKING AND PULMONARY IMMUNITY AND DISEASE | 694 | ||
| SMOKING AND TB | 695 | ||
| SMOKING AND PNEUMONIA | 697 | ||
| SMOKING AND INFLUENZA | 697 | ||
| SMOKING AND HIV | 698 | ||
| SMOKING AND COPD | 698 | ||
| CONVERGENCE OF TB, HIV, COPD, PNEUMONIA, AND INFLUENZA | 698 | ||
| SUMMARY | 699 | ||
| REFERENCES | 699 | ||
| Chapter 10. Extensively Drug-resistant Tuberculosis: Epidemiology and Management Challenges | 705 | ||
| INSIGHTS FROM CLINICAL EPIDEMIOLOGY | 706 | ||
| INSIGHTS FROM MOLECULAR EPIDEMIOLOGY | 707 | ||
| DIAGNOSIS OF MDR AND XDR-TB | 712 | ||
| MANAGEMENT CHALLENGES | 717 | ||
| ETHICAL DILEMMAS | 718 | ||
| SUMMARY | 719 | ||
| REFERENCES | 720 | ||
| Chapter 11. Childhood Tuberculosis: An Emerging and Previously Neglected Problem | 727 | ||
| EVIDENCE OF EMERGENCE | 728 | ||
| INCREASED AWARENESS | 730 | ||
| PROGRAMMATIC BARRIERS | 731 | ||
| DIAGNOSTIC DILEMMA | 732 | ||
| TB AND HIV COINFECTION | 738 | ||
| TREATING CHILDREN WITH TB | 740 | ||
| DRUG RESISTANCE | 742 | ||
| RESEARCH PRIORITIES | 745 | ||
| SUMMARY | 745 | ||
| REFERENCES | 745 | ||
| Chapter 12. Tuberculosis in the Global Aging Population | 751 | ||
| EPIDEMIOLOGIC TRANSITION OF TUBERCULOSIS | 751 | ||
| RISK FACTORS FOR TB | 756 | ||
| PREVENTIVE TREATMENT | 758 | ||
| OTHER PREVENTION STRATEGIES | 762 | ||
| CLINICAL DISEASE AMONG THE ELDERLY | 763 | ||
| FUTURE PERSPECTIVE | 765 | ||
| Chapter 13. Nontuberculous Mycobacterial Lung Diseases | 769 | ||
| EPIDEMIOLOGY | 769 | ||
| PATHOGENESIS | 772 | ||
| CLINICAL FEATURES | 774 | ||
| DISEASE PATTERNS WITH NTM OTHER THAN MAC | 777 | ||
| DIAGNOSIS | 778 | ||
| TREATMENT | 780 | ||
| SUMMARY | 784 | ||
| REFERENCES | 784 | ||
| Chapter 14. Emerging Advances in Rapid Diagnostics of Respiratory Infections | 791 | ||
| ANTIGEN DETECTION | 792 | ||
| NUCLEIC ACID AMPLIFICATION TESTS | 793 | ||
| BREATH ANALYSIS | 800 | ||
| FUTURE PROSPECTS | 801 | ||
| REFERENCES | 801 | ||
| Chapter 15. Antiviral Drug Resistance: Mechanisms and Clinical Implications | 809 | ||
| HERPESVIRUSES | 809 | ||
| HERPES SIMPLEX VIRUS | 811 | ||
| VARICELLA ZOSTER VIRUS | 812 | ||
| CYTOMEGALOVIRUS | 813 | ||
| HEPATITIS B VIRUS | 817 | ||
| THE FUTURE | 821 | ||
| Index | 835 |